Search research articles
Contact Us
Filters
Showing results (191-200 of 199) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 199 results.
Journal of Medicinal Chemistry
|
March 6, 2023
Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis <i>In Vivo</i>
John T Randolph, Matthew J O'Connor, Fei Han, et al.
Journal of Medicinal Chemistry
|
June 5, 2025
Validation, Key Pharmacophores, and X-ray Cocrystal Structures of Novel Biochemically and Cellularly Active WRN Inhibitors Derived from a DNA-Encoded Library Screen
Yunsong Tong, Kenton A Baker, Alex M Chapman, et al.
Epilepsia
|
September 9, 2005
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity
William J Giardina, Michael J Dart, Richard R Harris, et al.
Gut
|
June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
Shahida Din, Alexandra Kent, Richard C Pollok, et al.
Journal of Crohn'S & Colitis
|
May 12, 2023
DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making
Misha Kabir, Siwan Thomas-Gibson, Phil J Tozer, et al.
Gut
|
April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists
Arthur Gomtsyan, Robert G Schmidt, Erol K Bayburt, et al.
Journal of Medicinal Chemistry
|
May 25, 2026
Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors
Reza Shiroodi, Timothy J Montavon, Brandon M Nelson, et al.
Orphanet Journal of Rare Diseases
|
February 23, 2023
Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
S Ingen-Housz-Oro, V Schmidt, M M Ameri, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 199) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 199 results.
Journal of Medicinal Chemistry
|
March 6, 2023
Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis <i>In Vivo</i>
John T Randolph, Matthew J O'Connor, Fei Han, et al.
Journal of Medicinal Chemistry
|
June 5, 2025
Validation, Key Pharmacophores, and X-ray Cocrystal Structures of Novel Biochemically and Cellularly Active WRN Inhibitors Derived from a DNA-Encoded Library Screen
Yunsong Tong, Kenton A Baker, Alex M Chapman, et al.
Epilepsia
|
September 9, 2005
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity
William J Giardina, Michael J Dart, Richard R Harris, et al.
Gut
|
June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
Shahida Din, Alexandra Kent, Richard C Pollok, et al.
Journal of Crohn'S & Colitis
|
May 12, 2023
DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making
Misha Kabir, Siwan Thomas-Gibson, Phil J Tozer, et al.
Gut
|
April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists
Arthur Gomtsyan, Robert G Schmidt, Erol K Bayburt, et al.
Journal of Medicinal Chemistry
|
May 25, 2026
Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors
Reza Shiroodi, Timothy J Montavon, Brandon M Nelson, et al.
Orphanet Journal of Rare Diseases
|
February 23, 2023
Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
S Ingen-Housz-Oro, V Schmidt, M M Ameri, et al.
Page
of 20